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Abstract 
Antigenic variation is an immune evasion strategy that has evolved in viral, bacterial 
and protistan pathogens. In the African trypanosome this involves stochastic switches 
in the composition of a Variant Surface Glycoprotein (VSG) coat, using a massive 
archive of silent VSG genes to change the identity of the single VSG expressed at a 
time. VSG switching is driven primarily by recombination reactions that move silent 
VSGs into specialised expression sites, though transcription-based switching can also 
occur. Here we discuss what is being revealed about the machinery that underlies 
these switching mechanisms, including what parallels can be drawn with other 
pathogens. In addition, we discuss how such switching reactions act in a hierarchy 
and contribute to pathogen survival in the face of immune attack, including the 
establishment and maintenance of chronic infections, leading to host-host 
transmission. 
 
Antigenic variation in African trypanosomes 
African trypanosomes are protistan parasites that infect a range of mammals and are 
transmitted between successive hosts by the tsetse fly. In all mammals, the parasites 
replicate extracellularly in the tissue fluids and bloodstream. Despite continuous 
exposure to immune attack trypanosome infections can be very prolonged, causing a 
range of pathological manifestations (Barrett et al., 2003). Trypanosome persistence 
in the mammal is due to antigenic variation, which involves changes in the identity of 
the Variant Surface Glycoprotein (VSG), which forms a dense cell surface coat that 
shields invariant surface antigens from immune recognition. Antibodies against the 
VSG kill the trypanosome, but the population survives due to stochastic switching to a 
coat composed of an antigenically distinct VSG. The rate of VSG switching (up to 10-
3 switchers/cell/division)(Turner and Barry, 1989) is typical of what Moxon and 
colleagues termed ‘enhanced phenotypic variation’ (Moxon et al., 1994) in subset of 
genes in viral, bacterial and eukaryotic pathogens (Deitsch et al., 2009).  
Trypanosomes have made a huge investment in antigenic variation. The genome of T. 
brucei contains >1600 VSG genes (Marcello and Barry, 2007), hugely in excess of 
antigenic variation gene families elsewhere (Table 1). Most (80-90%) of this VSG 
archive is in 11 diploid, megabase-sized chromosomes; the subtelomeres harbour 
silent VSG arrays (Berriman et al., 2005), while sites for VSG transcription, termed 
the VSG expression sites (ES) (Fig.2), are found directly proximal to the telomeres 
(Hertz-Fowler et al., 2008). Only a minority (~5%) of VSG array genes are functional, 
with the large majority (~85%) being pseudogenes (Marcello and Barry, 2007), which 
(in common with other pathogens) provide a critical resource during antigenic 
variation. T. brucei has also evolved novel, aneuploid chromosomes to facilitate 
antigenic variation. Minichromosomes (Wickstead et al., 2004) are present in ~100 
copies per cell and harbour VSGs at their ends, suggesting they evolved to expand the 
telomeric pool of VSGs (Barry et al., 2003). Intermediate chromosomes are related to 
minichromosomes (Wickstead et al., 2004) and contain ES. These chromosomes may 
also be a product of the evolutionary drive to expand the VSG archive, or may indicate 
selection for increased flexibility in ES-associated gene (ESAG) expression (see 
below). Two modes of VSG switching occur: recombination reactions that move 
silent VSGs into the ES, or transcriptional switches in which the single actively 
transcribed ES is silenced and a silent ES becomes actively transcribed. Given that the 
overwhelming number of archival VSGs are outwith the ES, recombinational 
switching is the main player in T. brucei antigenic variation.  
Recombination mechanisms in T. brucei antigenic variation  
Three recombination pathways contribute to VSG switching. The extent to which the 
underlying recombination machinery is shared by these pathways, and whether or not 
each can occur by different recombination reactions, is being dissected. Additionally, 
VSG switching by recombination operates in a hierarchy (Capbern et al., 
1977;Morrison et al., 2005), the basis for which is not fully understood. In the 
hierarchy, telomeric VSGs are activated earliest in infections, followed by intact 
subtelomeric array VSGs, and finally pseudogenes, which are recombined to form 
functional VSG ‘mosaics’ (Marcello and Barry, 2007;Morrison et al., 2005;Thon et 
al., 1990). 
The most commonly described recombination pathway is gene conversion, where a 
silent, functional VSG is copied and transferred to the ES, replacing the resident VSG 
(Fig.1). The sequence copied in this reaction normally extends beyond the VSG ORF. 
Upstream, the boundary is often degenerate 70 bp repeats (Liu et al., 1983), which 
flank virtually all VSGs (~90%) (Marcello and Barry, 2007), whereas gene 
conversions in which a silent ES acts as VSG donor can extend much further upstream 
(Pays et al., 1983), even including the VSG promoter ~50 kbp distant (Hertz-Fowler et 
al., 2008). Downstream, gene conversion of array VSGs can extend to the 3’ coding or 
non-coding parts of the gene (Bernards et al., 1981), or to the chromosome end (de 
Lange et al., 1983). A number of recombination models can account for VSG gene 
conversion. Synthesis-dependent strand-annealing (SDSA) does not generate 
crossovers and has been invoked (Barry, 1997;Borst et al., 1996) as it avoids 
potentially lethal translocations when array VSGs are copied into the ES (Fig.1B). 
However, given that a substantial minority of VSGs are telomeric, break-induced 
replication (BIR) has also been suggested (Barry and McCulloch, 2001;Dreesen et al., 
2007). BIR (Fig. 1D) is enzymatically and kinetically distinct from SDSA (Lydeard et 
al., 2007), primarily in that involves repair by a processive DNA replication fork 
established from one end of a DNA double strand break (DSB). In yeast, BIR can 
stabilise telomeric repeats using subtelomeric sequences (Lydeard et al., 2007), and 
this may be promoted in T. brucei VSG switching by the preponderance of conserved 
subtelomeric sequences, such as the 70 bp repeats. In addition, long-range VSG gene 
conversions (Hertz-Fowler et al., 2008) may be better explained by BIR than SDSA. 
Nevertheless, no genetic or mechanistic dissection has shown that SDSA and BIR 
both act in VSG switching. Moreover, if both reactions do act, it is highly likely that 
BIR is important only for activation of telomeric VSGs, while SDSA can activate any 
gene in the archive.  
A second recombination pathway has been termed reciprocal, telomeric VSG 
exchange (Pays et al., 1985). Here, chromosome ends are exchanged by crossover, 
moving a silent telomeric VSG into the active ES and retaining the previously active 
VSG on the other chromosome, most likely by double strand break repair (Fig. 1B). It 
seems this is a minor pathway of VSG switching. Indeed, recent work has suggested 
that the ES undergo extensive recombination within the ESAGs upstream of the VSG 
(Hertz-Fowler et al., 2008), and it is possible that VSG reciprocal exchange might be a 
by-product of this activity.  
A final recombination pathway is used to generate novel, functional VSGs by 
combining portions of the ORFs from at least two pseudogenes to yield VSG mosaics 
(Thon et al., 1990). A number of observations suggest this is a distinct pathway to 
intact VSG gene conversion. First, this appears to be a relatively inefficient reaction, 
with VSG mosaics observed late in infections (Marcello and Barry, 2007). 
Nevertheless, the huge number of VSG pseudogenes suggests this is very important 
(Barbet and Kamper, 1993), expanding the VSG coat repertoire beyond that encoded 
directly from the genome. Second, in mosaic gene conversion recombination occurs 
within the VSG ORFs, rather than flanking homology, despite VSGs sharing very 
limited overall primary sequence homology. Third, mosaic VSG formation involves 
multiple donor genes, with a functional gene most likely built up sequentially by 
segmental gene conversions. Finally, activation of intact VSGs almost certainly targets 
the ES (Boothroyd et al., 2009), but it is unclear if this is also the case for mosaic 
VSG formation. Sequencing the bloodstream stage ES repertoire in one T. brucei 
strain revealed that each site possesses a functional VSG adjacent to the telomere 
(Hertz-Fowler et al., 2008) and it is unclear if the VSG pseudogenes sometimes 
observed upstream are assembly intermediates.  
Molecular players in antigenic variation by recombination 
VSG switching, at least of intact VSGs, occurs by exploiting homologous 
recombination (HR), a universally conserved DNA repair mechanism (San Filippo et 
al., 2008). Mutation of three key factors of HR has been shown to impair (not 
abrogate) VSG switching: RAD51, the central enzyme of HR (McCulloch and Barry, 
1999), and BRCA2 (Hartley and McCulloch, 2008) and RAD51-3 (Proudfoot and 
McCulloch, 2005), distinct proteins that mediate RAD51 activity (San Filippo et al., 
2008). These data show striking parallels with Neisseria type IV pili antigenic 
variation (Hill and Davies, 2009), which occurs by gene conversion of silent, non-
functional pilS genes to a  pilE expression locus. This is dependent on RecA, the 
bacterial homologue of eukaryotic RAD51, exploiting each available subpathway of 
RecA-dependent HR, initiated by a RecF-like route (Mehr and Seifert, 1998) or by 
recBCD (though the evidence for this is controversial, and may be strain-
specific)(Hill et al., 2007). T. brucei VSG gene conversion also appears to exploit 
different recombination sub-pathways: residual VSG gene conversion in RAD51 
mutants suggests RAD51-independent recombination can act, while four RAD51 
paralogues appear to make non-equivalent contributions to VSG switching (R. 
Dobson, C.Stockdale and R. McCulloch, unpublished)(Proudfoot and McCulloch, 
2005). Intriguingly, the contribution of mismatch repair (MMR) to antigen gene 
conversion in the two organisms also shows parallels. MMR recognises and repairs 
base mismatches, which can occur during recombination between sequence-diverged 
DNA molecules, in which context MMR suppresses recombination. Surprisingly, 
mutation of neither mutS in N. gonorrhoeae nor the eukaryotic orthologue, MSH2, in 
T. brucei alters antigenic variation frequency, despite elevating rates of mutation and 
HR (Bell and McCulloch, 2003;Hill and Davies, 2009). This could suggest the gene 
conversion reactions are not subject to normal MMR surveillance, which for T. brucei 
could implicate an MMR-independent HR reaction (Barnes and McCulloch, 2007). 
Alternatively, MMR may function both to initiate and regulate antigen recombination, 
nullifying the phenotype of any mutation.  
The use of both antigen pseudogenes and intact genes for gene conversion in a single 
pathogen is rare (Table 1). To date, approaches in T. brucei have only assayed for the 
recombination factors that contribute to, or have modelled experimentally (Boothroyd 
et al., 2009), recombination of intact VSGs. Nevertheless, comparison with other 
pathogens may provide clues regarding mosaic VSG formation. B.  burgdorferi 
antigenic variation involves recombining silent vls segments into a vlsE ES (Norris, 
2006) and looks superficially similar to that of Neisseria, but is RecA-independent 
(Liveris et al., 2008). The explanation for this difference my reside in the fact that 
VlsE antigenic variation involves apparently random segmental conversions from 
multiple vls donors, without any clear homology sequences guiding the reaction 
(Zhang and Norris, 1998). This contrasts with the ‘mini-cassette’ process of Neisseria 
pilS gene conversion (Hill and Davies, 2009), which is normally guided by upstream 
and downstream flanking sequence homology, similar to the recombination of intact 
vlp/vsp genes in B. hermsii (Dai et al., 2006). In principle, therefore, B. burgdorferi 
antigenic variation appears more similar to A. marginale msp2 gene conversion, 
which employs only a very small donor archive and uses segmental gene conversion 
to generate huge numbers of variants (Futse et al., 2005). This reaction appears to be 
‘anchored’ by sequence homology at one flank, but is resolved in regions of limited 
homology, allowing huge recombinatorial flexibility (Futse et al., 2005). Two 
speculations seem warranted. First, it is likely that B. hermsii antigenic variation 
compares with gene conversion of intact T. brucei VSGs and Neisseria pilS genes in 
being driven by RecA/Rad51-dependent recombination. Second, the segmental gene 
conversion reactions that underlie T. brucei VSG and A. marginale msp2 mosaic gene 
formation, like B. burgdorferi vlsE switching, are (at least partly) RecA/Rad51-
independent. Segmental gene conversion pathways may have evolved to elaborate 
antigenic variation, allowing highly protracted infections marked by huge antigen 
variability and allowing superinfection in partly immune hosts. What features are 
common to those pathogens that employ only intact genes are less clear; this is not 
limited to intracellular pathogens (Table 1), but may be used where a relatively 
precise surface antigen activation hierarchy is seen, such as in B. hermsii (Barbour et 
al., 2006).  
Initiation of VSG switching 
A question long unanswered in any pathogen, is how are recombination-based 
switching events initiated? DSBs within the antigen ES have been suggested as the 
likeliest culprit (Barry, 1997;Borst et al., 1996;Hill and Davies, 2009) and recently 
Boothroyd et al. (Boothroyd et al., 1980) provided evidence that that this may be so 
for T. brucei VSG switching. Controlled generation of a DSB adjacent to the 70 bp 
repeats in the active ES increased the rate of VSG switching and initiated VSG gene 
conversion. In addition, using ligation-mediated PCR, DNA breaks could be detected 
within the 70 bp repeats upstream of the VSG in the active ES, but much less readily 
(if at all) in an inactive ES. The 70 bp repeats have been predicted as the site of 
initiation previously (Barry, 1997;Liu et al., 1983), but further work is needed to 
determine how they act (Barry and McCulloch, 2009). This may not be 
straightforward, as several observations appear at odds with the suggestion that the 70 
bp repeat breaks always initiate VSG switching. First, both previous work 
(McCulloch et al., 1997) and Boothroyd et al (Boothroyd et al., 2009) examined VSG 
switching in T. brucei cells expressing VSG from an ES engineered to lack 70 bp 
repeats. Neither study could detect differences in switch frequency compared with T. 
brucei expressing VSG from the same ES when a large array of 70 bp repeats was 
retained. Second, in all eukaryotes DNA breaks elicit a DNA damage response, 
allowing the cell to co-ordinate repair with cell cycle progression. For DSBs, a key 
factor is the Mre11-Rad50-Nbs1/Xrs2 complex (Harper and Elledge, 2007), but 
mutation of MRE11 in T. brucei has no discernible effect on VSG switching 
(Robinson et al., 2002), even though the protein is clearly important for genome 
stability (Robinson et al., 2002;Tan et al., 2002). Finally, generation of a DSB 
appeared not to recapitulate the full diversity of VSG switching events, in that all 
switching reactions used telomeric VSGs as donors (>80% residing in silent ES). This 
raises the question of whether DSBs also elicit switching of intact array VSGs or VSG 
pseudogenes. Indeed, we do not yet know if DSBs in the ES recruit RAD51 for HR, 
as seen elsewhere in the genome (Glover et al., 2008).  
What is the role of VSG transcriptional switching, and how is it catalysed? 
Antigenic variation relies on the expression of a single ES from many, a process 
termed allelic exclusion (Borst and Genest, 2006). An important context to understand 
this process is the observation (Navarro and Gull, 2001) that the active ES, which is 
transcribed by RNA polymerase (Pol) I, does not localise to the nucleolus (as 
expected for PolI-transcribed genes such as rRNA) but to a putative subnuclear site 
termed the expression site body (ESB). A model for the functioning of the ESB 
(whose constitution remains unknown) is that it accommodates only a single ES, 
explaining why attempts to select for trypanosomes expressing >1 ES yield only 
unstable, rapidly switching intermediates (Chaves et al., 1999). Recently, a number of 
factors have been described whose mutation or RNAi-mediated knockdown results in 
derepression of transcription from the silent ES. Each factor influences chromatin 
structure, and in each case derepression affected differing amounts of the ES 
transcription units (Fig. 2). RNAi of TbISWII, a SWI2/SNF-2-related chromatin 
remodelling factor, leads to a  ~30 fold increase in transcripts of genes proximal to the 
ES promoter (Hughes et al., 2007). Conversely, RNAi of TbRAP1, which in yeast 
binds telomeres and contributes to heterochromatin formation, causes a 2-50 fold 
increases in VSG transcripts from the silent ES, but lesser derepression proximal to 
the promoter (Yang et al., 2009). A similar telomere-mediated effect is seen in histone 
deacetylase TbSir2 mutants (Alsford et al., 2007), but limited to the region 
downstream of the VSGs. Finally, RNAi of DOT1B, one of two T. brucei histone H3 
methyltransferases, results in ~10 fold depression of the whole silent ES transcription 
unit (Figueiredo et al., 2008). In addition, DOT1B RNAi caused accumulation of cells 
expressing two VSGs on the cell surface, indicating a perturbation in VSG coat 
transition during switching. These studies reveal that a number of epigenetic 
processes contribute to singular ES expression, but it is striking that the extent of 
silent ES de-repression never reveals transcription to the levels from the active site, 
and the frequency of VSG switching appears not to change (where tested). It seems, 
likely, therefore, that these are secondary processes that follow from the establishment 
of singular expression. Moreover, the factors, and potential triggers, that mediate 
transcriptional switching remain elusive for trypanosomes, as for pathogens 
exclusively reliant on this reaction, such as P. falciparum (Scherf et al., 2008).  
A broader question about transcriptional switching in trypanosomes is the purpose of 
this reaction. Given the overwhelming numbers of silent VSGs that must be activated 
by recombination, does the presence of ~20 ES add much to antigenic variation, or 
does it contribute another function? It has been suggested that the reason for 
possessing multiple ES may lie in the ESAGs, not the VSGs (Bitter et al., 1998;Young 
et al., 2008). ESAG6 and ESAG7 form a heterodimeric receptor for host transferrin, 
supplying the parasite with iron. A host-range hypothesis has stemmed from this, 
suggesting that transcriptional switching reveals different transferrin receptors 
adapted to the different mammalian hosts trypanosomes infect (Bitter et al., 1998). 
This has been extended to other ESAGs and, though questioned by others (Steverding, 
2006), would suggest that transcriptional switching provides a means for infection 
establishment. However, we cannot yet exclude that transcriptional switching 
provides antigenic variation functions throughout a chronic infection: the silent ES 
may provide sites for the generation of VSG mosaics (Barry and McCulloch, 2001), or 
might provide a failsafe switch mechanism when VSG pseudogenes are switched into 
the active ES. Understanding the evolution of the VSG system for antigenic variation 
would shed light on this (Barry and McCulloch, 2001). For instance, do 
transcriptional and recombinational switching reactions share a common trigger? 
Infection dynamics and antigenic variation 
The essence of the antigenic variation system in trypanosomes is to ensure survival 
within the mammal to allow transmission to the next host, via the tsetse vector. The 
system is clearly efficient, since infections in experimental cattle can last for hundreds 
of days (Luckins and Mehlitz, 1976), while human infections can have a prepatent 
period of years before clinical signs emerge (Barrett et al., 2003). This picture of a 
chronic disease is not mirrored by the majority of the trypanosome antigenic variation 
literature, which, largely due to experimental restrictions, has concentrated on the first 
peaks of parasitaemia, essentially the initiation and establishment of infection. Despite 
these shortcomings, studies that have ventured into the chronic phase of infection  
(Capbern et al., 1977;Kamper and Barbet, 1992;Marcello and Barry, 2007;Morrison 
et al., 2005;Thon et al., 1990) have revealed some intriguing insights into the 
dynamics and functioning of antigenic variation. 
Antigenic variation occurs independently of host immune responses as a stochastic 
process. However, it is antibody selection that results in the observed hierarchy of 
VSG expression. Experimental infections and mathematical modelling suggest the 
first peak of parasitaemia is controlled by a combination of density dependent growth 
arrest and immunity (Lythgoe et al., 2007;Morrison et al., 2005). The sequential 
expression of VSGs that follows is a product of cumulative antibody responses that 
select against the more frequently activated VSGs as the infection progresses. As we 
have argued above, VSG switching is two-tiered, using one form of recombination 
(mosaic VSG formation) that is VSG-sequence homology-dependent, and another 
(gene conversion of intact VSGs) driven by sequence homology in the flanking 
regions. Mosaic VSG formation is relatively rare (Barry, 1997;Kamper and Barbet, 
1992;Thon et al., 1990) and predominates later in infection (Marcello and Barry, 
2007). This difference in rate of switching between VSG classes provides some basis 
for understanding the VSG hierarchy, but a modelling analysis (Lythgoe et al., 2007) 
suggests further subtleties. Within the limitations of the model, only by grouping 
genes into subsets with distinct ranges of switching probabilities could a realistic 
representation of in vivo infection dynamics be generated. These groupings may 
correspond to (a) those genes that comprise intact and functional open reading frames 
that are switched to by a simple single-step recombination reaction, and (b) 
pseudogenes requiring more than a single recombination event to create an intact ORF 
and functional protein. Within these probability clusters there is further hierarchy; for 
example, within (a), probability of switching has been experimentally demonstrated to 
be dependent upon the locus position of the donor sequence (Aline, Jr. et al., 1985;Liu 
et al., 1985;Morrison et al., 2005;Robinson et al., 1999) or (b), dependent upon the 
number of recombination events required to create a functionally expressed VSG, 
from involving few sequences (Pays et al., 1983) to multiple and complex 
recombinations (Kamper and Barbet, 1992;Marcello and Barry, 2007). Several 
aspects remain unclear, however. Most prominently, we do not yet know if the 
transition to mosaic VSG formation involves a change in dominance of switching 
mechanisms per se (i.e. specific recombination pathway differences), mainly because 
recombination pathway responsible has not been characterised. The demonstration of 
RAD51-independent recombination in T. brucei requiring as little as 7-13 bp of 
homology (Conway et al., 2002;Glover et al., 2008) suggests a pathway, but this 
remains to be tested. There may be further mechanistic differences in VSG switching 
at the species level. The VSG archive of T. brucei is now fairly well characterised, but 
those of T. congolense and T. vivax have not been similarly analysed. Genome 
projects are present for both (http://www.genedb.org/), and preliminary analysis 
suggests that T. congolense does not have the 70-bp repeat system of T. brucei (L. 
Marcello, PhD thesis), hinting that phenotypic similarities in infection profiles may 
hide mechanistic differences in VSG switching. 
Recombination-based determinants of switch hierarchy have been described during 
antigenic variation in other pathogens. In B. hermsii the activation probability of silent 
(functionally intact) vlp/vsp genes appears to be dependent on the sequence homology 
and positioning, respectively, of upstream and downstream homology elements 
(Barbour et al., 2006). A. marginale also displays a hierarchy, but using only 
pseudogenes: simple msp2 mosaics appear preferentially early in infection and more 
complex mosaic genes predominate later, in the presence of a patent specific immune 
response to the earlier, simple mosaics (Palmer et al., 2007). It has been suggested 
that the simple mosaic confer a fitness advantage over the complex mosaics, but this 
fitness advantage is balanced by the simple mosaics being more immunogenic 
(Zhuang et al., 2007). A potential explanation for antigens expressed early in 
infection being more immunogenic is that if the switching probability matrix is 
maintained throughout infection, they will be continuously switched to, giving rise to 
a persistent stimulation of the immune response to those epitopes. Once the antibody 
response against these epitopes is patent, further switches to these commonly 
switched to antigens will be redundant, but the maintenance of this spectrum of 
switching probability throughout infection will result in the characteristic profile (in 
trypanosomes and Anaplasma) of large, early parasitaemic peaks followed by 
intermittent and smaller peaks (Lythgoe et al., 2007)(i.e. a reduction in the effective 
switching rate). Variant fitness requires addressing in trypanosome chronic infections, 
as this may be due to cross-reactive epitopes, as suggested in Anaplasma, but also 
potentially the creation of non- (or less-) functional VSGs as the more complex (and 
less probable) mosaic formation occurs, and consequently reduced fitness of the 
trypanosome expressing that VSG. In addition, homology-driven switching is likely to 
generate VSGs with epitopes that are cross-reactive with patent immune responses, 
and such cross-reactivity has been suggested to play a vital role in determining 
Plasmodium infection dynamics (Recker et al., 2004). Cross reaction between 
immune responses to VSGs has not been observed in trypanosome infections 
(Capbern et al., 1977;Morrison et al., 2005;Robinson et al., 1999;Van Meirvenne et 
al., 1975), although it is a phenomenon that has not specifically been searched for. 
Given the recent description of loss of memory B cells during trypanosome infections 
(Radwanska et al., 2008), it might be expected that this immunosuppression will 
allow increased tolerance of cross-reactive epitopes generated as the infection 
progresses. Loss of immunological memory may explain the reappearance of early 
variants late in infection observed in mice, rabbits and goats (but not cattle)(Barry, 
1986). Immune selection at a population level, combined with homology-driven 
switching, may drive VSG archive evolution down homology-mediated routes, 
explaining how strain divergence in VSG repertoire develops (Hutchinson et al., 
2007). The continual generation of antigenic diversity at the repertoire level is 
essential to allow the parasite to overcome herd immunity (Futse et al., 2008). 
Antigenic variation undoubtedly combines with other parasite- and host-driven 
mechanisms to maintain chronicity.  Probably the most important parasite 
determinant, other than the antigenic variation system, for maintaining chronic 
infections is the self-regulation of growth by the density-dependent differentiation of 
mitotically dividing long slender bloodstream form cells to non-dividing short stumpy 
form cells, which are pre-adapted to initiate infection in the tsetse fly midgut (Barry 
and McCulloch, 2001). The interplay of differentiation and antigenic variation are key 
(Lythgoe et al., 2007;Tyler et al., 2001), and the recent identification of a key marker 
of differentiation will allow this relationship to be examined in detail (Dean et al., 
2009). Further fitness advantages that allow an increased time window for a 
successful switch to novel variants may be at the population level and more generic, 
such as hydrodynamic uptake and removal of bound antibody (Engstler et al., 2007), 
or the advantages conferred by different trypanosome transferrin receptors (Bitter et 
al., 1998). These multiple mechanisms, along with the VSG switching dynamics, will 
contribute to the evolution of fitness within the host. Certainly, when superinfections 
with a different strain of trypanosome are attempted in an animal with an established 
infection, the strain that is established does seem to have a fitness advantage 
(Morrison et al., 1982).  
In summary, the availability of post-genomic tools has begun the exploration of 
several key aspects of antigenic variation, revealing underlying mechanisms and VSG 
switching dynamics in the chronic stage of infection. Understanding this stage may 
explain the apparently uniquely enormous antigen repertoire in trypanosomes, and 
identification of the molecular mechanism of mosaic VSG formation will inform how 
infection time and potential for transmission is maximised. Appreciating the diversity 
of host-parasite interactions is important. Combining markers for both parasite (VSG 
switching and stumpy formation) and host (immune response and antibodies) will 
result in better overall understanding of how trypanosomiasis manifests as a chronic 
disease, and potentially provide opportunities for disease intervention.  
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Figure legends 
Figure 1. Recombination models for VSG switching by gene conversion. A 
Recombination is shown initiated by a DNA double strand break (DSB) in the 70 bp 
repeats (hatched) upstream of the VSG (black arrow) in the active expression site. 
DSB processing reveals 3’ single-stranded ends, a reaction in which MRE11-RAD50-
XRS2/NBS1 acts, providing a substrate for RAD51 to form a nucleoprotein filament. 
RAD51 function is aided by a number of factors, including BRCA2 and multiple 
RAD51 paralogues (not shown). RAD51 catalyses homology-dependent invasion of 
the single-stranded end into intact DNA duplex (grey lines) containing a silent VSG 
(grey arrow); mismatch repair (MMR) limits recombination to sufficiently 
homologous sequences. Three pathways for DSB repair can be used. B shows double 
strand break repair, where newly synthesised DNA is copied from the intact DNA 
duplex and remains base-pared, leading to Holliday junction recombination 
intermediates, whose enzymatic resolution can lead to gene conversion with (not 
shown) or without (shown) cross-over of flanking sequences. C shows synthesis-
dependent strand annealing, where newly replicated DNA is displaced from the intact 
duplex, re-anneals with homologous sequence at the DSB, allowing synthesis of the 
other strand. In D, break-induced replication, an origin-independent replication fork, 
with leading and lagging strand synthesis, forms on the strand invasion intermediate 
allowing replication to the chromosome end. 
Figure 2. VSG mosaic formation by segmental gene conversion. A VSG gene (blue 
box) is shown within an expression site (ES), which is represented as an archetype of 
such a transcription unit: expression site associated genes are shown as functional 
(black box) or pseudogenes (grey box) and are identified by number; repeat sequences 
within (70 bp repeats) or upstream (50 bp repeats) of the ES are indicated by hatched 
boxes; the promoter is indicated by an arrow; and the telomere by a vertical line. 
Segmental gene conversion of three silent VSG genes from the subtelomeric array 
archive is diagrammed, indicating segments from each ORF being combined (arrows) 
to replace the transcribed VSG. The inset shows details of an experimentally verified 
VSG mosaic (adapted from Marcello and Barry, 2007). Three silent VSG pseudogene 
donor ORFs are shown below the mosaic sequence of the functional VSG (identified 
as an expressed cDNA): colours indicate regions of sequence homology between the 
donors and the cDNA, and the potential junctions in the gene conversion(s); overall 
sequence identity is shown.  
Figure 3. VSG switching hierarchy in T. brucei. The graph shows the numbers of T. 
brucei cells (parasitaemia) measured in a cow up to 70 days post-infection (plotted as 
the prepatent period, in days, that a 0.2 ml inoculum of cattle blood achieves a 
parasitaemia of 1×108.1 trypanosomes.ml−1units in a mouse; adapted from Morrison et 
al, 2005). Below is a depiction of the timing of VSG switch mechanism usage and 
gene activation. Transcriptional switching is proposed to occur at the outset of an 
infection, whereas recombination switching is used throughout; note, the former 
proposal is not experimentally verified. Silent telomeric VSGs are activated more 
frequently that intact, subtelomeric array VSGs, which are activated more frequently 
than VSG pseudogenes. During recombinational switching, VSG flanking sequence 
(e.g. 70 bp repeats) is proposed to mediate the VSG switching reactions of intact genes 
early in infections, whereas the formation of VSG mosaics relies on recombination 
using the genes’ ORF sequences later in infections. The intensity of shading in each 
bar represents the effective switching rate, i.e. the proportion of switches that give rise 
to novel VSGs.  
Table 1. Antigenic variation systems in eukaryotic and bacterial pathogens. 
aVSG, variant surface glycoprotein; MSG, major surface glycoprotein; VSP, variant 
specific surface protein; VES1, variant erythorocyte surface antigen, of both α and β 
types; VAR encodes P. falciparum erythrocyte membrane protein 1; VLP/VSP, 
variable large protein/variable small protein; VLS, Vmp-like sequence; PIL encodes 
the type IV pilus; MSP2, major surface protein 2.  
b N/A; not applicable 
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